Article
Prognostic Impact of Central Nervous System Recurrence After Surgery in Patients With Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer.
Anticancer research - 1 Aug 2023
Okamoto Tatsuro, Takenaka Tomoyoshi, Yamazaki Koji, Hamatake Motoharu, Miura Naoko, Takenoyama Mitsuhiro, Kometani Takuro, Ueda Hitoshi, Kouso Hidenori, Yano Tokujiro
Abstract excerpt
BACKGROUND/AIM: Adjuvant therapy using third-generation tyrosine kinase inhibitors (TKI) demonstrated improved central nervous system (CNS) disease-free survival after surgery in patients with epidermal growth factor receptor (EGFR) mutation-positive lung cancer. However, the prognostic impact of CNS recurrence in surgical patients remains unknown. We evaluated the effect of CNS recurrence on post-recurrence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
